Naproxcinod
In Stock•Starting at $427 for 5 mg•Purity ≥ 97%
| CAS No. | 163133-43-5 |
|---|---|
| MDL No. | MFCD08705752 |
| MF | C18H21NO6 |
| MW | 347.40 |
| InChI Key | AKFJWRDCWYYTIG-ZDUSSCGKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 97% | $427 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Naproxcinod is a carboxylic ester formed by the condensation of naproxen's carboxy group with the hydroxy group of 4-(nitrooxy)butanol. It acts as a cyclooxygenase-inhibiting nitric oxide donor, metabolizing to naproxen and a nitric oxide-donating moiety. It is used in the treatment of osteoarthritis. It functions as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a prodrug, a nitric oxide donor, and an EC 1.14.99.1 inhibitor. It is a nitrate ester, a carboxylic ester, and a methoxynaphthalene. It is functionally related to naproxen and butane-1,4-diol.
| CAS No. | 163133-43-5 |
|---|---|
| Product Name | Naproxcinod |
Biological Targets
PTGS2·PTGS1
Associated Conditions
osteoarthritis·kidney failure·osteoarthritis, hip·liver disease·rheumatic disease
* The information provided here is compiled from public sources and is for reference only.
